The FDA, the National Institutes of Health (NIH) and Various Clinical Studies have Findings about Belladonna that are Contrary to Hyland’s Statement
The U.S. Food and Drug Administration (FDA) released a consumer warning in September of 2016, regarding the use of Hyland’s homeopathic teething gel and tablets. In the warning, the FDA warned parents to stop using the homeopathic teething products in treating their babies’ pain, due to the 400 cases of adverse events (seizures, fevers and vomiting) and 10 infant deaths which may be connected to the use of Hyland’s products; the warning also advised parents to dispose of all teething products that may still be in their possession. Besides the FDA, the the American Academy of Pediatrics’ HealthyChildren.org also cautioned parents to keep away from teething tablets that contain belladonna and gels that contain benzocaine.
In 2010, six years before this advisory, a similar warning was released by the FDA. However, aside from warning consumers of the possible risk that Hyland’s Teething Tablets pose in children, the FDA also said that its laboratory analysis found that the teething tablets contain inconsistent amounts of belladonna. This finding is contrary to Hyland’s claim that its homeopathic teething tablets contain only a small amount of belladonna.
Belladonna, also called devil’s cherry or deadly nightshade, comes from the belladonna plant which, though poisonous, has been used as a medicine for hundreds of years. Its medicinal properties have also made it an active ingredient in numerous homeopathic medications, including Hyland’s Teething products.
The FDA, the National Institutes of Health (NIH) and various clinical studies, however, all say that there is not enough evidence that will prove that Belladonna is effective for any of the uses printed on its product label. Instead of stating that it is effective, the FDA rather says that large doses of medications, specifically teething products, which contain this drug can be fatal, especially to babies.
Hyland’s Inc.’s teething tablets are intended to provide temporary relief from teething discomfort, including simple restlessness and wakeful irritability. Their safety and effectivity are continuously affirmed by Hyland’s despite the two warnings already issued by the FDA and the adverse cases reported to the same government agency. In the light of these warnings and reports, by the way, Hyland’s has decided to discontinue distribution of its teething products.
Many websites, such as that of Williams Kherkher with address, http://www.williamskherkher.com/practice-areas/defective-pharmaceuticals/hyland-teething-tablet-lawsuit/, provide helpful information about teething tablet which you and all other parents will surely be interested to know. The site also talks about teething tablet lawsuit, symptoms of teething tablet toxicity and what to do, especially if you notice any of the symptoms of belladonna poisoning being displayed by your baby.